missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Lymphotoxin beta R (LTbR) Fc Chimera
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 629-LR-100
404.31 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human Lymphotoxin beta R (LTbR) Fc Chimera is derived from NS0. The Recombinant Human Lymphotoxin beta R (LTbR) Fc Chimera has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 49.6 kDa (monomer) | |
| 100 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 4055 | |
| Lymphotoxin beta R/TNFRSF3 Fc Chimera | |
| Mouse myeloma cell line,NS0-derived human Lymphotoxin beta R/TNFRSF3 protein, (N-terminus) Human LT beta R (Ser28-Met227) & (Gln31-Met227) Accession &Num; NP_002333 DIEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |